The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage
Background: To investigate how serum sST2 and cfDNA can be used to inform evidence-based nursing practices for children with severe pneumonia and myocardial damage. Methods: 100 children with severe pneumonia complicated with myocardial damage were recruited as research subjects. After assessing ser...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Society of Medical Biochemists of Serbia, Belgrade
2025-01-01
|
| Series: | Journal of Medical Biochemistry |
| Subjects: | |
| Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504748D.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849416704245891072 |
|---|---|
| author | Du Meng Jia Haoran Zhao Tingting Liu Ye Wang Dexing Wang Weiwei |
| author_facet | Du Meng Jia Haoran Zhao Tingting Liu Ye Wang Dexing Wang Weiwei |
| author_sort | Du Meng |
| collection | DOAJ |
| description | Background: To investigate how serum sST2 and cfDNA can be used to inform evidence-based nursing practices for children with severe pneumonia and myocardial damage. Methods: 100 children with severe pneumonia complicated with myocardial damage were recruited as research subjects. After assessing serum sST2 and cfDNA concentrations, the individuals were categorised into a control cohort (receiving standard treatment, n=50) and an experimental cohort (receiving evidence-based treatment guided by serum sST2 and cfDNA markers, n=50). Collected were the general details of the two patient groups. Biochemical analysis of patient serum sST2 and cfDNA changes was performed before and after care. Echocardiography was used to measure the left ventricular ejection fraction (LVEF) and left ventricular internal diameter (LVIDd) both before and after treatment of the patient. Levels of procalcitonin and C-reactive protein were assessed using enzyme-linked immunosorbent assay (ELISA) before and after patient treatment, while the white blood cell count in blood samples was determined using an automated haematology analyser. The patients' pneumonia resolution and length of hospital stay were compared. Patient satisfaction with care plans was compared through rating questionnaires. Results: The general information of the two groups of patients showed no significant difference (P>0.05). Before receiving nursing care, there were no significant variations in serum sST2 and cfDNA levels among the two patient groups (P>0.05). Following the nursing period, the observation group exhibited decreased serum sST2 and cfDNA levels compared to the control group (P<0.05). Before nursing care, there were no significant variations in left ventricular ejection fraction and left ventricular internal diameter in diastole among the two cohorts of patients (P>0.05). Following nursing, the observation group exhibited a higher LVEF than the control group and a smaller LVIDd (P<0.05). Before receiving nursing care, there were no significant variations in procalcitonin, hs-CRP, and white blood cell count between the two patient groups (P>0.05). Following care, the observation group exhibited decreased levels of procalcitonin, hs-CRP, and white blood cell count compared to the control group (P<0.05). The pneumonia remission and hospitalisation duration in the observation group were significantly shorter than in the control group (P<0.05). Conclusions: The importance of serum sST2 and cfDNA indicators in evidence-based nursing for children with severe pneumonia and myocardial damage is highlighted, showing significant improvement in treatment outcomes and patient satisfaction, confirming the crucial role of these biomarkers in enhancing nursing care plans. |
| format | Article |
| id | doaj-art-202e2571cc404c958414d1bc8d10aee5 |
| institution | Kabale University |
| issn | 1452-8258 1452-8266 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Society of Medical Biochemists of Serbia, Belgrade |
| record_format | Article |
| series | Journal of Medical Biochemistry |
| spelling | doaj-art-202e2571cc404c958414d1bc8d10aee52025-08-20T03:33:07ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662025-01-0144474875810.5937/jomb0-520851452-82582504748DThe clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damageDu Meng0Jia Haoran1Zhao Tingting2Liu Ye3Wang Dexing4Wang Weiwei5Capital Medical University, Baoding Hospital of Beijing Children's Hospital, Neonatology, Baoding, ChinaCapital Medical University, Baoding Hospital of Beijing Children's Hospital, Neonatology, Baoding, ChinaCapital Medical University, Baoding Hospital of Beijing Children's Hospital, Neonatology, Baoding, ChinaCapital Medical University, Baoding Hospital of Beijing Children's Hospital, Neonatology, Baoding, ChinaCapital Medical University, Baoding Hospital of Beijing Children's Hospital, Pediatrics, ChinaCapital Medical University, Baoding Hospital of Beijing Children's Hospital, Pediatrics, ChinaBackground: To investigate how serum sST2 and cfDNA can be used to inform evidence-based nursing practices for children with severe pneumonia and myocardial damage. Methods: 100 children with severe pneumonia complicated with myocardial damage were recruited as research subjects. After assessing serum sST2 and cfDNA concentrations, the individuals were categorised into a control cohort (receiving standard treatment, n=50) and an experimental cohort (receiving evidence-based treatment guided by serum sST2 and cfDNA markers, n=50). Collected were the general details of the two patient groups. Biochemical analysis of patient serum sST2 and cfDNA changes was performed before and after care. Echocardiography was used to measure the left ventricular ejection fraction (LVEF) and left ventricular internal diameter (LVIDd) both before and after treatment of the patient. Levels of procalcitonin and C-reactive protein were assessed using enzyme-linked immunosorbent assay (ELISA) before and after patient treatment, while the white blood cell count in blood samples was determined using an automated haematology analyser. The patients' pneumonia resolution and length of hospital stay were compared. Patient satisfaction with care plans was compared through rating questionnaires. Results: The general information of the two groups of patients showed no significant difference (P>0.05). Before receiving nursing care, there were no significant variations in serum sST2 and cfDNA levels among the two patient groups (P>0.05). Following the nursing period, the observation group exhibited decreased serum sST2 and cfDNA levels compared to the control group (P<0.05). Before nursing care, there were no significant variations in left ventricular ejection fraction and left ventricular internal diameter in diastole among the two cohorts of patients (P>0.05). Following nursing, the observation group exhibited a higher LVEF than the control group and a smaller LVIDd (P<0.05). Before receiving nursing care, there were no significant variations in procalcitonin, hs-CRP, and white blood cell count between the two patient groups (P>0.05). Following care, the observation group exhibited decreased levels of procalcitonin, hs-CRP, and white blood cell count compared to the control group (P<0.05). The pneumonia remission and hospitalisation duration in the observation group were significantly shorter than in the control group (P<0.05). Conclusions: The importance of serum sST2 and cfDNA indicators in evidence-based nursing for children with severe pneumonia and myocardial damage is highlighted, showing significant improvement in treatment outcomes and patient satisfaction, confirming the crucial role of these biomarkers in enhancing nursing care plans.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504748D.pdfsst2cfdnasevere pneumoniamyocardial damageevidence-based nursing |
| spellingShingle | Du Meng Jia Haoran Zhao Tingting Liu Ye Wang Dexing Wang Weiwei The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage Journal of Medical Biochemistry sst2 cfdna severe pneumonia myocardial damage evidence-based nursing |
| title | The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage |
| title_full | The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage |
| title_fullStr | The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage |
| title_full_unstemmed | The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage |
| title_short | The clinical value of serum sST2 and cfDNA in guiding evidence-based nursing care for children with severe pneumonia complicated by myocardial damage |
| title_sort | clinical value of serum sst2 and cfdna in guiding evidence based nursing care for children with severe pneumonia complicated by myocardial damage |
| topic | sst2 cfdna severe pneumonia myocardial damage evidence-based nursing |
| url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2025/1452-82582504748D.pdf |
| work_keys_str_mv | AT dumeng theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT jiahaoran theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT zhaotingting theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT liuye theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT wangdexing theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT wangweiwei theclinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT dumeng clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT jiahaoran clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT zhaotingting clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT liuye clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT wangdexing clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage AT wangweiwei clinicalvalueofserumsst2andcfdnainguidingevidencebasednursingcareforchildrenwithseverepneumoniacomplicatedbymyocardialdamage |